Evaluation of the Cepheid GeneXpert BCR-ABL Assay
- 1 April 2007
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 9 (2) , 220-227
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- β-Glucuronidase Is an Optimal Normalization Control Gene for Molecular Monitoring of Chronic Myelogenous LeukemiaThe Journal of Molecular Diagnostics, 2006
- Molecular Monitoring of Chronic Myelogenous LeukemiaThe Journal of Molecular Diagnostics, 2006
- Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical TestingClinical Chemistry, 2005
- Chronic Myeloid Leukemia: Current Application of Cytogenetics and Molecular Testing for Diagnosis and TreatmentMayo Clinic Proceedings, 2005
- Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome–positive chronic-phase chronic myeloid leukemia after failure of interferon-αBlood, 2004
- Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer programLeukemia, 2003
- Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer ProgramLeukemia, 2003
- A further milestone towards comprehensive standardization of quantitative RT-PCR protocols for leukemic fusion gene transcripts has been reachedLeukemia, 2003
- Clinical Applications of BCR-ABL Molecular Testing in Acute LeukemiaThe Journal of Molecular Diagnostics, 2003
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996